跳转至内容
Merck
CN

S4026

甲基环己亚硝脲

别名:

N-(2-氯乙基)-N′-(4-甲基环己基)-N-亚硝基脲, 甲基-CCNU

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C10H18ClN3O2
化学文摘社编号:
分子量:
247.72
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI

1S/C10H18ClN3O2/c1-8-2-4-9(5-3-8)12-10(15)14(13-16)7-6-11/h8-9H,2-7H2,1H3,(H,12,15)

SMILES string

CC1CCC(CC1)NC(=O)N(CCCl)N=O

InChI key

FVLVBPDQNARYJU-UHFFFAOYSA-N

Application

常用于药理学研究,包括:
  • 对营养敏感的筛选,用于将能量代谢从线粒体呼吸转变为糖酵解的药物
  • CEOP方案结合司莫司汀,用于淋巴瘤患者的诱导化疗
  • 应用于化疗的研究

pictograms

Skull and crossbonesHealth hazard

signalword

Danger

Hazard Classifications

Acute Tox. 2 Oral - Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Carc. 1B - Eye Irrit. 2 - Repr. 1B - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

[Clinical significance of mustoforan in management of malignant glioma].
G L Kobiakov
Voprosy onkologii, 53(6), 724-729 (2008-04-18)
[Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection].
Su-Zhan Zhang
Zhonghua zhong liu za zhi [Chinese journal of oncology], 32(11), 801-803 (2011-01-13)
1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea.
Report on carcinogens : carcinogen profiles, 11, III53-III53 (2004-01-01)
Eleana Ntatsaki et al.
Rheumatology (Oxford, England), 50(6), 1019-1024 (2011-02-05)
The ANCA-associated vasculitides (AAVs) are conventionally treated with a strategy of remission induction followed by maintenance therapy using glucocorticoids combined with CYC during induction and AZA for maintenance. Recently, several randomized controlled trials have been published that question whether these
Qiu-bai Li et al.
Acta pharmacologica Sinica, 30(10), 1471-1478 (2009-09-22)
To analyze the results of idarubicin (IDA)- versus etoposide (VP16)-intensified myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation (allo-SCT) for high-risk acute leukemia. From January 2005 to June 2008, 48 consecutive patients (male: n=29; median age: 30 years, range

相关内容

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持